Integrated Biopharma, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2020
May 13, 2020 at 04:37 pm EDT
Share
Integrated BioPharma, Inc. announced earnings results for the third quarter ended March 31, 2020. For the third quarter, the company announced sales was USD 13.631 million compared to USD 14.088 million a year ago. Operating income was USD 960,000 compared to USD 1.237 million a year ago. Net income was USD 936,000 compared to USD 923,000 a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to USD 0.03 a year ago. For the nine months, sales was USD 39.234 million compared to USD 36.393 million a year ago. Operating income was USD 2.641 million compared to USD 2.130 million a year ago. Net income was USD 2.207 million compared to USD 1.328 million a year ago. Basic earnings per share from continuing operations was USD 0.07 compared to USD 0.05 a year ago.
Integrated Biopharma Inc. is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements, and herbal products. The Companyâs business segments include Contract Manufacturing operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; and Other Nutraceutical Businesses, which includes the operations of AgroLabs, Inc. (AgroLabs), The Vitamin Factory (the Vitamin Factory), IHT Health Products, Inc. (IHT), MDC Warehousing and Distribution, Inc., and Chem International, Inc. AgroLabs distributes healthful nutritional products for sale through mass market, grocery and drug and vitamin retailers under the brands: Peaceful Sleep, and Wheatgrass and other products. IHT is a distributor of fine natural botanicals, including multi-minerals produced under a license agreement. Chem is a distributor of raw materials.
INTEGRATED BIOPHARMA, INC. 
